襄州区DHL国际物流公司 襄州DHL快递电话 襄州DHL快递代收点 襄州区DHL国际快运，全球的国际快递服务提供商 DHLExpress 已通过 DHL Medical Express (WMX)为制药和临床研究领域的客户推出了墨西哥和美国之间的增强服务。DHL 于 2017年在墨西哥试行的运输解决方案限度地降低了在复杂供应链中运营的客户的风险。该服务对于有益于和拯救人类生命的医学研究和临床试验至关重要。
凭借其医疗快递服务，DHL Express可以管理具有特定温度要求的紧急货物的出口和监管要求——从墨西哥的几个主要城市，包括墨西哥城、瓜达拉哈拉和蒙特雷——在不到 24小时的时间内到达美国的大多数目的地。
通过 DHL WMX临床试验平台，该公司在墨西哥的市场网络得到了加强，该平台包括一个专门的客户服务中心，为研究人员配备双语代表。该服务包括干冰供应和温控包装履行、用于预订和订购供应的在线工具，以及连接站点的基于Web 的界面快递物流平台 (ELP)。DHL 客户服务团队和所有运营后台系统驻留在 DHL 运营中，也集成到 ELP 中。
“鉴于墨西哥和其他几个拉丁美洲国家的出口流程和卫生部批准的复杂性，拥有集成系统使 DHL能够在样品到达我们的设施之前开始出口批准流程，”生活部门主管 Brian Bralynski 说科学，DHL 美洲。“这使 DHL能够将稍后的收集时间延长到调查人员站点，从而有更多时间安排患者就诊，并且仍然导出收集日期。”
DHL 于 2014年从哥伦比亚推出了其综合医疗快递服务，此后将该服务扩展到阿根廷、智利、哥斯达黎加、多米尼加共和国、厄瓜多尔、危地马拉、巴拿马和秘鲁。在不久的将来，这项服务的扩展计划包括巴西和墨西哥境内的其他市场。
“DHL Medical Express 满足了制药行业和临床研究领域对服务的行业关键需求，”DHL ExpressAmericas 执行官 Mike Parra说。“这是一个非常有效的解决方案，因为我们强大的国际网络以及对药品、检测试剂盒和诊断样本进出口所涉及的监管要求的深入了解。”
由于 DHL Express拥有自己的运输网络，因此该公司可以提供响应速度、可靠性和成本效益的组合。通过专门的热包装（常温、冷藏和冷冻）、预先确定的应急措施来避免延误以及通过其质量控制中心进行24/7运输主动监控，获得该服务的合格客户可以选择温度选项。该服务能够运输实验室试剂盒和医疗设备、生物样本（血液、唾液、尿液、组织等）、研究产品、疫苗、商业和非商业用途的药物以及医疗设备。
DHL是家进入拉丁美洲市场的集成商，提供面向临床研究领域需求的综合服务，*终目标是提供一致的患者结果。它代表了历史上服务于拉丁美洲地区的传统/承运人的新市场替代品。
DHL Express, the world’s leading international expressservices provider, has launched an enhanced service between Mexicoand the United States for customers in the pharmaceutical andclinical research sectors through DHL Medical Express (WMX). Thetransportation solution, which DHL piloted in Mexico in 2017,minimizes the risks for customers operating within a complex supplychain. The service is vital for medical research and clinicaltrials that benefit and save human lives.
With its medical express service, DHL Express can manage theexport and regulatory re for urgent shipments withspecific temperature re – from several major cities inMexico, including Mexico City, Guadalajara and Monterrey – to mostU.S. destinations in less than 24 hours.
The company’s market-leading network in Mexico has beenenhanced via the DHL WMX clinical trial platform, which includes aspecialized Customer Service Center with bilingual representativesfor investigator sites. The service includes dry ice supplies andtemperature-controlled packaging fulfillment, online tools forplacing bookings and ordering supplies, and a web-based interface,Express Logistics Platform (ELP), that connects sites. The DHLcustomer service team and all the operational back office systemsreside within the DHL operation and are also integrated intoELP.
“Given the complexity of export processes and Ministry ofHealth approvals in Mexico and several other Latin Americancountries, having an integrated system enables DHL to begin theexport approval process ahead of samples arriving at ourfacilities,” said Brian Bralynski, Sector Head of Life Sciences,DHL Americas. “This enables DHL to extend later collection times toinvestigator sites, allowing more time to schedule patient visitsand still export the day of collection.”
DHL launched its integrated Medical Express service fromColombia in 2014 and has since expanded the service to Argentina,Chile, Costa Rica, Dominican Republic, Ecuador, Guatemala, Panamaand Peru. Expansion plans for this service in the near futureinclude Brazil and additional markets within Mexico.
“DHL Medical Express answers an industry-critical need for aspecialized service in the pharmaceutical industry and clinicalresearch sectors,” said Mike Parra, CEO of DHL Express Americas.“It’s a very effective solution because of our strong internationalnetwork and intimate knowledge of the regulatory reinvolved in the import and export of pharmaceuticals, test kits anddiagnostic specimens.”
Since DHL Express sources its own transportation network, thecompany can offer the best combination of responsiveness,reliability and cost-effectiveness. customers for theservice receive a choice of temperature options through specializedthermal packaging (ambient, chilled and frozen), pre-determinedcontingencies to circumvent delays and 24/7 shipment pro-activemonitoring through its Control Centers. The service iscapable of transporting laboratory kits and medical devices,biological samples (blood, saliva, urine, tissues, etc.), researchproducts, vaccines, drugs for commercial and non-commercial use,and medical devices.